Mixed amphetamine salts

Sujin Lee Weinstein, Pharm.D., BCPP

INDICATIONS

Attention deficit hyperactivity disorder (ADHD) in adults and children (IR > 3 years old, XR > 6 years old, Mydayis > 13 years old), narcolepsy in pediatrics > 6 years old and adults (Only the immediate-release tablets are approved for narcolepsy.)

Treatment-resistant depression, cocaine-use disorder

There's more to see -- the rest of this topic is available only to subscribers.

All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.